Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
104M
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
7.99M
-
Shares change
-
+207K
-
Total reported value, excl. options
-
$4.84M
-
Value change
-
+$105K
-
Put/Call ratio
-
0.01
-
Number of buys
-
13
-
Number of sells
-
-9
-
Price
-
$0.61
Significant Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q2 2024
33 filings reported holding VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share as of Q2 2024.
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.99M shares
of 104M outstanding shares and own 7.72% of the company stock.
Largest 10 shareholders include Lagoda Investment Management, L.P. (5.44M shares), VANGUARD GROUP INC (637K shares), GEODE CAPITAL MANAGEMENT, LLC (635K shares), BlackRock Inc. (516K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (174K shares), Silverberg Bernstein Capital Management LLC (145K shares), STATE STREET CORP (124K shares), NORTHERN TRUST CORP (89.3K shares), MORGAN STANLEY (89.2K shares), and UBS Group AG (66.9K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.